Neoadjuvant Chemotherapy for Transitional Cell Carcinoma of the Bladder: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Neoadjuvant Chemotherapy for Transitional Cell Carcinoma of the Bladder: A Systematic Review and Meta-Analysis

Published:2004-02 Issue:2 Volume:171 Page:561-569
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

WINQUIST ERIC¹,KIRCHNER TRICIA S.¹,SEGAL ROANNE¹,CHIN JOSEPH¹,LUKKA HIMU¹,

Affiliation:

1. From the London Regional Cancer Centre (EW) and London Health Sciences Centre (JC), London, Cancer Care Ontario Program in Evidence-based Care, McMaster University (TSK) and Hamilton Regional Cancer Centre (HL), Hamilton and Ottawa Regional Cancer Centre (RS), Ottawa, Ontario, Canada

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference62 articles.

1. Radical cystectomy for bladder cancer today—a homogeneous series without neoadjuvant chemotherapy;Madersbacher;J Clin Oncol,2003

2. Chemotherapy for urothelial cancer;Bajorin,1997

3. A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors;Logothetis;J Clin Oncol,1990

4. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a co-operative group study;Loehrer;J Clin Oncol,1992

5. A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate, and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council Study. MRC Advanced Bladder Cancer Working Party;Mead;Br J Cancer,1998

Cited by 311 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival outcomes in patients with muscle-invasive bladder cancer receiving neoadjuvant chemotherapy stratified by number of cycles;Clinical Genitourinary Cancer;2024-09

2. Advanced bladder cancer detection: Innovations in biomarkers and nanobiosensors;Sensing and Bio-Sensing Research;2024-08

3. Alignment of molecular subtypes across multiple bladder cancer subtyping classifiers;Urologic Oncology: Seminars and Original Investigations;2024-06

4. Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancer;Scientific Reports;2024-01-16

5. Risk factors for failing to complete gemcitabine–cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients;Investigative and Clinical Urology;2024